Nutritional Sciences

The Korean Nutrition Society (한국영양학회)
권호 표지

Effects of Soy Isoflavones on Lipid Profiles and Hepatic LDL Receptor mRNA Level in Growing Female Rats

  • Jo, Hyun-Ju (Department of Medicinal Food & Health, World Cyber College) ;
  • Choi, Mi-Ja (Department of Food & Nutrition, Keimyung University) ;
  • Yoo, Min (Department of Biology, Keimyung University)
  • Published : 2006.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

The present study examined the effect of soy isoflavones on lipid metabolism in growing female rats. Rats were randomly assigned to three different groups and provided experimental diets for 9 weeks. The experimental groups were classified into 1) a control group, 2) a soy protein isolate group: soy (+)) group and 3) a soy protein concentration group: soy (-)) group. Diets contained either casein or one of two soy proteins with (soy (+)) or without isoflavones (soy (-)). Serum triglyceride concentration showed no significant differences among the experimental groups. Serum total cholesterol concentration was significantly lower in both the soy (+) and soy (-) groups than in the control group and LDL-cholesterol concentration was significantly lower in the soy (+). Serum HDL-cholesterol concentration was significantly higher in the control group than in the soy protein groups but the HDL-cholesterol share rate in total cholesterol tended to be lower in the control group than in the soy protein groups, insignificant as it was. Hepatic IDL receptor mRNA level was significantly increased in the soy (+) group when compared to the other two groups to be 20% higher than the control group. In conclusion, soy protein isolate, soy protein rich with isoflavones reduced serum total cholesterol and LDL-cholesterol concentration and increased hepatic IDL receptor mRNA expression in growing female rats. Therefore, it is considered that the intake of soy isoflvones during puberty can be advantageous in terms of the long-tenn control of serum lipid.

Keywords

References

  1. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obest Gynecol 87:897-890, 1996
  2. Potter SM. Soy protein and cardiovascular disease: the impact of bioactive components in say. Nutr Rev 56:231-235, 1998 https://doi.org/10.1111/j.1753-4887.1998.tb01754.x
  3. Demonty I, Lamarche B, Jones PJ. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 61: 189-203, 2003 https://doi.org/10.1301/nr.2003.jun.189-203
  4. Zhou JR. Say and the prevention of lifestyle-related diseases. Clin Exp Pharmacol Physiol 31:S14-S19, 2004 https://doi.org/10.1111/j.1440-1681.2004.04123.x
  5. Zhan S, Ha SC. Meta-analysis of the effects of say protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:937-408, 2005
  6. Messina M, Messina V. Saoyfoods, soybean isoflavones, and health: a brief overview. J Ren Nutr 10(2):63-68, 2000 https://doi.org/10.1016/S1051-2276(00)90001-3
  7. Setchell KDR, Borriella SP, Hulme P, Axelson M. Nonsteroidal estrogens of dietary origin: Possible roles in hormone dependent disease. Am J Clin Nutr 40:569-578, 1984 https://doi.org/10.1093/ajcn/40.3.569
  8. Song TT, Hendrich S, Murphy PA. Estrogenic activity of glycitein, a Soy Isoflavone. J Agric Food Chem 47:1607-1610, 1999 https://doi.org/10.1021/jf981054j
  9. Kuiper GJM, Lemmen JG, Calsson B. Interaction of estrogen chemicals and phytoestrogens with estrogen receptor ${\beta}.$ Endocrinology 139:4252-4263, 1998 https://doi.org/10.1210/en.139.10.4252
  10. Engelman HM, Alekel DL, Hanson LN, Kanthasamy AG, Reddy MB. Blood lipid and oxidative stress responses ta say protein with isoflavones and phytic acid in postmenopausal women. Am J Clin Nutr 81:590-596, 2005 https://doi.org/10.1093/ajcn/81.3.590
  11. Makela S, Davis VL, Tally WC. Dietary estrogens act through estrogen receptor mediated processes and show no anti-estrogenicity in cultured breast cancer cells. Environ health perspect 102:572-578, 1994 https://doi.org/10.1289/ehp.94102572
  12. Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94:739-743, 1994 https://doi.org/10.1016/0002-8223(94)91939-9
  13. Martin RM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 198:1860-1867, 1978
  14. Setchel KDR, Nechemias LZ, Cai J, heubi JE. isoflavones content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68(Suppl):1453s-1461s, 1988
  15. Brown MS, Kovanen PT, Goldstein JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628-635, 1981 https://doi.org/10.1126/science.6261329
  16. Baum JA, Teng H, Erdman JW Jr. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551, 1998 https://doi.org/10.1093/ajcn/68.3.545
  17. Li C, Briggs MR, Ahlborn TE, Kreamer FB, Liu J. Requirement of Sp1 and estrogen receptor alpha interaction in 17 beta-estradiol mediated transcription activation of the low density lipoprotein receptor gene expression. Endocrinology 142(4): 1546-1553, 2001 https://doi.org/10.1210/en.142.4.1546
  18. Tavia G, William BK. Menopause and coronary heart disease: Framingham study. Ann Intern Med 89:157-161, 1978 https://doi.org/10.7326/0003-4819-89-2-157
  19. Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 366(Pt 2):531-539, 2002 https://doi.org/10.1042/BJ20020046
  20. Sirtori CR, Lovati MR, Manzoni C. Soy and cholesterol reduction: clinical expirience. J Nutr 125(suppl):598s-605s, 1995
  21. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:728-735, 2001 https://doi.org/10.1093/ajcn/73.4.728
  22. Strong JP, Malcom GT, McMahan CA. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA 281:727-735, 1999 https://doi.org/10.1001/jama.281.8.727
  23. National Institutes of Health, National Heart, Lung, and Blood. Report of the Expert Panel or Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program. Bethesda. NIH Publication No. 91-27-32, 1991
  24. Lee SK, Lee MJ, Yoon S, Kwon DJ. Estimated isoflavone intake from soy products in korean middle-aged women. J Korea Soc Food Sci Nutr 29:948-956, 2000
  25. Haglund O, Loustarinen R, Wallin R, Wibell I, Saldeen T. The effect of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin. Eur J Nutr 121:165-172, 1991 https://doi.org/10.1093/jn/121.2.165
  26. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of ultracentrafuge. Clin Chem 18:499-502, 1972
  27. Folch J, Lees M, Sloanestanley GH. Asimple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226 :497-509, 1957
  28. Arjmandi AH, Getlinger MJ, Goyal NV, Alekel L, Hasler CL, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rat. Am J Clin Nutr 68(Suppl):1358s-1363s, 1998
  29. Kim, MS. Beneficial effect of soy isoflavone on bone loss and hyperlipidemia ovariectomized rats. Dissertation of Ph.D, Seoul National University, 1999
  30. Choi, MJ. Effects of soy protein on bone mineral content and bone mineral density in growing male rat. Kor J Nutr 35:409-413, 2002
  31. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterrolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:225-231, 2001 https://doi.org/10.1093/ajcn/73.2.225
  32. Zhuo XG, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: ameta-analysis of 8 randomized controlled trials humans. J Nutr 134:2395-2400, 2004 https://doi.org/10.1093/jn/134.9.2395
  33. Teixeira BH. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids. Am J Clin Nutr 71:1074-1084, 2000
  34. Kurowska EM, Carroll KK. Hypercholesterolemic responses in rabbits to selected groups of dietary essential amino acids. J Nutr 124:364-370, 1994
  35. Krtcihevsky D. Dietary protein and experimental atherosclerosis. Ann NY Acad Sci 676:180-187, 1993 https://doi.org/10.1111/j.1749-6632.1993.tb38733.x
  36. Huff MW, Carroll KK. Effects of dietary proteins and amino acid mixtures on plasma cholesterol leverls in rabbits. J Nutr 110:1676-1685, 1980 https://doi.org/10.1093/jn/110.8.1676
  37. Shorey RL, Day PJ, Willis RA. Effects of soybean polysaccharide on plasma lipids. J Am Diet Assoc 85:1461-1465, 1985
  38. Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr 28:764-774, 1975 https://doi.org/10.1093/ajcn/28.7.764
  39. Sidhy GS, Oakenfull DG. A mechanism for hypocholesterolemic activity of saponins. Br J Nutr 55:643-649, 1986 https://doi.org/10.1079/BJN19860070
  40. Anthony MS, Clarkson TB, Hughes, CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubetral rhesus monkeys. J Nutr 126:43-50, 1996 https://doi.org/10.1093/jn/126.1.43
  41. Sacks FM, Breslow JL, Wood PG, Kass EH. Lack of an effect of dietary protein and soy protein on plasma cholesterol of strict vegetarians. J Lipid Res 24:1012-1020, 1983
  42. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29:23-39. 2002 https://doi.org/10.1677/jme.0.0290023
  43. Hotron JD, Cuthbert JA, Spady DK. Dietary fatty acids regulate hepatic low density lipoprotein(LDL) transport by altering LDL receptor protein and mRNA levels. J Clin Invest 92:743-749, 1993 https://doi.org/10.1172/JCI116645
  44. Connor WE, DB Stone, RE Hodges. The interrelated effects of dietary cholesterol and fat upon human serum lipid levels. J Clin Invest 43:1691-1696, 1964 https://doi.org/10.1172/JCI105044
  45. Jayo MJ, Anthony MS, Register C, Rankin SE, Best T, Clarkson TB. Dietary soy isoflavones and bone loss; a study in ovariectomized monkeys. J Bone Mineral Res 11:s228(Abstr), 1996
  46. Lees CJ, Ginn TA. Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macques. Calcif Tissue Int 62:557-558, 1998 https://doi.org/10.1007/s002239900479
  47. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes care 25:1709-1714, 2002 https://doi.org/10.2337/diacare.25.10.1709
  48. Jay D. Horton, Jennifer A. Cuthbert, Danid K. Spady. Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA Levels. J Clin Invest 92:743-749, 1993 https://doi.org/10.1172/JCI116645
  49. Lovati MR, Manzoni C, Canavesi A. Soybean protein diet increases low density lipoptotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80:1498-1502, 1987 https://doi.org/10.1172/JCI113232
  50. Potter SM. Soy protein and serum lipids. Curr Opin Lipidol 7:260-264, 1996 https://doi.org/10.1097/00041433-199608000-00013
  51. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 28:954-959, 1998
  52. Choi MJ, Jo HJ. Effect of isoflavones supplemented diet on lipid concentration and hepatic LDL receptor mRNA level in growing female rats. Kar J Nutr 38: 1-8, 2005